Polygraphic examination
ProcedurePolygraphic examination between 30 and 36 weeks of amenorhea
NCT Number: NCT02029859
Main objective:
Determine the prevalence of obstructive sleep apnea syndrome (OSA) in late pregnancy in a population of obese patients .
Secondary objectives :
* Identify risk factors for OSA during pregnancy (age, parity, high blood pressure, snoring , weight, neck circumference, scores on symptoms of sleep apnea, ... ) . * Compare perinatal morbidity among obese patients with OSA in late pregnancy with case-controls. * Evaluate the evolution of a moderate or severe OSA 6 months after pregnancy.
Material and methods
Characteristics of the study:
* Interventional biomedical research * Prospective Multicenter nonrandomized study
Flow chart
* Patients will be included between 30 and 36 weeks of amenorrhea (WA) . * Will rated from inclusion: age, parity, weight, height, BMI in early pregnancy, neck circumferrence, treated high blood pressure. * As recommended in France, the main test results during the pregnancy follow-up will be recorded. * At the inclusion visit will be conducted a Berlin Questionnaire and Epworth Score. * Screening for OSA by nocturnal polysomnography will be performed between 30 and 36WA. This screening can be performed as an outpatient. * In case of proven OSA patients will be offered an appropriate care by today's standards. * Whatever the outcome of pregnancy, a second polysomnography will be performed 6 months after childbirth in case of OSA during pregnancy.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Angers University Hospital, Angers, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Polygraphic examination between 30 and 36 weeks of amenorhea
Time frame: 6 weeks
Polygraphic examination for all subjects will determine the sleep apnea syndrom prevalence during late pregnancy (after 30 weeks of amenorhea) for severe obese women (BMI>35).
University Hospital, Rouen
Other
Acronym: GOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02701426
Behavior, Body Weight
Lille, France
View Trial DetailsNCT02924636
Body Weight, Female Urogenital Diseases and Pregnancy Complications
Lille, France
View Trial DetailsNCT00804765
Body Weight, Childhood Obesity
Paris, France
View Trial DetailsNCT02791568
Body Weight, Female Urogenital Diseases and Pregnancy Complications
Madison, Wisconsin, United States
View Trial Details